SAA
ABBV icon

Southeast Asset Advisors’s AbbVie ABBV Stock Holding History

Southeast Asset Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.67M Sell
21,450
-1,253
-6% -$278K 0.51% 32
2025
Q4 		$5.19M Sell
22,703
-2,608
-10% -$594K 0.49% 37
2025
Q3 		$5.86M Buy
25,311
+9,782
+63% +$1.99M 0.64% 23
2025
Q2 		$2.88M Buy
15,529
+207
+1% +$38.5K 0.34% 49
2025
Q1 		$3.21M Buy
15,322
+2,339
+18% +$455K 0.39% 40
2024
Q4 		$2.31M Sell
12,983
-414
-3% -$76.1K 0.28% 55
2024
Q3 		$2.65M Buy
13,397
+1
+0% +$187 0.29% 53
2024
Q2 		$2.3M Buy
13,396
+2
+0% +$331 0.28% 55
2024
Q1 		$2.44M Sell
13,394
-399
-3% -$68.8K 0.29% 52
2023
Q4 		$2.14M Buy
13,793
+261
+2% +$38.1K 0.28% 52
2023
Q3 		$2.02M Buy
13,532
+1,302
+11% +$191K 0.28% 46
2023
Q2 		$1.65M Buy
12,230
+1
+0% +$147 0.23% 60
2023
Q1 		$1.95M Buy
12,229
+2,630
+27% +$402K 0.29% 49
2022
Q4 		$1.55M Sell
9,599
-1,383
-13% -$212K 0.25% 55
2022
Q3 		$1.47M Sell
10,982
-1,659
-13% -$238K 0.25% 54
2022
Q2 		$1.94M Sell
12,641
-138
-1% -$21.1K 0.31% 45
2022
Q1 		$2.07M Buy
12,779
+502
+4% +$72.9K 0.28% 49
2021
Q4 		$1.66M Buy
12,277
+28
+0.2% +$3.31K 0.23% 61
2021
Q3 		$1.32M Buy
12,249
+1,882
+18% +$215K 0.22% 70
2021
Q2 		$1.17M Buy
10,367
+7,804
+304% +$879K 0.19% 71
2021
Q1 		$277K Buy
2,563
+444
+21% +$47.5K 0.05% 115
2020
Q4 		$227K Buy
+2,119
New +$204K 0.05% 123

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Southeast Asset Advisors's ABBV Position: Q1 2026 in Review

Southeast Asset Advisors reduced its AbbVie (ABBV) stake by 5.5% in Q1 2026, selling an estimated $278K and leaving 21,450 shares worth $4.67M. The position accounts for 0.51% of the portfolio, ranked #32.

Southeast Asset Advisors first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.86M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Southeast Asset Advisors held 21,450 shares of AbbVie worth $4.67M as of Q1 2026.
  • Southeast Asset Advisors sold 1,253 AbbVie shares in Q1 2026, an estimated $278K.
  • AbbVie made up 0.51% of Southeast Asset Advisors's portfolio in Q1 2026, its #32 holding.
  • Southeast Asset Advisors first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Southeast Asset Advisors's AbbVie position peaked at $5.86M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Southeast Asset Advisors's 13F filing for Q1 2026, filed 13 May 2026.